Related Experiment Videos
Soluble guanylyl cyclase expression is reduced in allergic asthma
Andreas Papapetropoulos1, Davina C M Simoes, Georgia Xanthou
1G. P. Livanos and M. Simou Laboratories, Evangelismos Hospital, Department of Critical Care and Pulmonary Services, University f Athens School of Medicine, Athens, Greece. apapapet@upatras.gr
American Journal of Physiology. Lung Cellular and Molecular Physiology
|September 7, 2005
Summary
Soluble guanylyl cyclase (sGC) expression significantly decreases in experimental asthma, contributing to airway hyperreactivity. This reduction in sGC, an enzyme crucial for airway smooth muscle relaxation, is observed at both mRNA and protein levels.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Molecular Biology
Background:
- Soluble guanylyl cyclase (sGC) is a key enzyme in the lungs, generating cyclic guanosine monophosphate (cGMP) to relax airway smooth muscle.
- Asthma is characterized by bronchoconstriction and airway hyperreactivity, but the role of sGC in this condition is not fully understood.
Purpose of the Study:
- To investigate changes in sGC expression in a murine model of allergic asthma.
- To determine if reduced sGC activity contributes to airway hyperreactivity observed in asthma.
Main Methods:
- Utilized a well-established murine model of allergic asthma induced by ovalbumin (OVA) sensitization and challenge.
- Assessed sGC subunit mRNA levels using real-time PCR and protein expression via Western blotting and immunohistochemistry.
- Evaluated airway hyperreactivity to methacholine and the effect of a selective sGC inhibitor (ODQ).
Main Results:
- Allergic asthma induced by OVA led to significant lung inflammation and airway hyperreactivity.
- Steady-state mRNA levels of sGC subunits (alpha1, alpha2, beta1) were reduced by 60-80% in asthmatic mouse lungs.
- Protein expression of sGC subunits alpha1, alpha2, and beta1 was decreased by 50-80%, with reduced expression noted in bronchial smooth muscle cells.
- Pharmacological inhibition of sGC with ODQ mimicked the airway hyperreactivity seen in asthma.
Conclusions:
- Experimental asthma is associated with a significant reduction in both mRNA and protein expression of soluble guanylyl cyclase subunits in the lungs.
- The decreased expression of sGC contributes to the airway hyperreactivity characteristic of asthma.
- Targeting sGC may represent a potential therapeutic strategy for managing asthma-related airway hyperresponsiveness.